Recent Updates — AWHL

Aspira Women's Health Inc. entered into a Subordinated Business Loan and Security Agreement dated July 1, 2026, with Agile Lending, LLC and Agile Capital Funding, LLC. The $1,050,000 principal amount of the secured term loan, which includes an estimated $441,000 in interest, is scheduled to mature on January 26, 2027. The proceeds will be used to refinance existing debt and for general corporate purposes. Aspira Women's Health Inc. provides women's health diagnostic services.

Aspira Women's Health Inc. entered into a separation agreement with former CEO Michael Buhle, who ceased serving as CEO effective June 17, 2026. The agreement, expected to be effective on or about July 6, 2026, includes a $200,000 cash severance package, six months of COBRA health insurance premiums, and accelerated vesting of 64,583 stock options at a $0.07 exercise price. Shares acquired through exercise of these options will be subject to lock-up and volume/price floor restrictions. Aspira Women's Health Inc. provides women's health diagnostic services.